Isotechnika Pharma Inc IPHAF

Time to get stealthy?

[wrongturn]

The head game continues. If it is Roche who is selling, I can't believe I'm saying this but may be Isa should shelf transplantation and halt the trials for this indication. Stop the bleeding and take any losses currently incurred. Go full force with psoriasis and find a marketing deal or partner with another firm for psoriasis to keep Isa afloat. Lay off employees and do what it takes to survive. Let the off sales of the psoriasis drug eventually spill over into transplantation. Let's face it, if Roche is not happy with Isa, they could probably drag the 90 day option out for years with its legal team. And does Isa want to spend millions fighting with a company it's supposed to have a working relationship with? Not likely. No other large pharma will go near Roche's pond, it's how large pharmas make their money so no other large pharma will partner with Isa for transplantation. Of course I'm just thinking aloud here. If Roche is selling, Mr Foster knows it. If Roche wants to slow progress with psoriasis, Mr Foster should consider shelving the transplant indication because his ultimate goal should be to keep Isa moving forward as a company I'm sure Roche would like to see the drug for both indications to come out concurrently, but that's not option Isa has financially. Let's face it, transplantation belongs to Roche. Yatscoff was great with the science but I question if he just had enough with the business side. I believe Yatscoff did say that the drug would cross the finish line. He just didn't say in who's hands.